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The use of extracellular matrix materials as scaffolds for the repair and regeneration of tissues is receiving
increased attention. The current study was undertaken to test whether extracellular matrix formed by osteoblasts
in vitro could be used as a scaffold for osteoblast transplantation and induce new bone formation in critical size
osseous defects in vivo. Human osteoblasts derived from alveolar bone were cultured in six-well plates until
confluent and then in mineralization media for a further period of 3 weeks to form an osteoblast–mineralized
matrix complex. Histologically, at this time point a tissue structure with a “connective tissue”-like morphol-
ogy was formed. Type I collagen was the major extracellular component present and appeared to determine
the matrix macrostructure. Other bone-related proteins such as alkaline phosphatase (ALP), bone morphogen-
etic protein (BMP)-2 and -4, bone sialoprotein (BSP), osteopontin (OPN), and osteocalcin (OCN) also accu-
mulated in the matrix. The osteoblasts embedded in this matrix expressed mRNAs for these bone-related proteins
very strongly. Nodules of calcification were detected in the matrix and there was a correlation between
calcification and the distribution of BSP and OPN. When this matrix was transplanted into a critical size
bone defect in skulls of immunodeficient mice (SCID), new bone formation occurred. Furthermore, the cells
inside the matrix survived and proliferated in the recipient sites, and were traceable by the human-specific
Alu gene sequence using in situ hybridization. It was found that bone-forming cells differentiated from both
transplanted human osteoblasts and activated endogenous mesenchymal cells. This study indicates that a
mineralized matrix, formed by human osteoblasts in vitro, can be used as a scaffold for osteoblast transplan-
tation, which subsequently can induce new bone formation.
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INTRODUCTION Scaffolds for tissue reconstruction and replacement
must have appropriate structural and functional proper-
The extracellular matrix consists of a complex mix- ties (2). Basic requirements for designing scaffolds for
ture of structural and functional proteins that play a tissue engineering include biodegradability, biocompati-
central role in cell and tissue differentiation and organi- bility, high surface area/volume ratio, mechanical integ-
zation. It has been demonstrated that modulation of ex- rity, and vascular and neural infiltration (21). In recent
tracellular matrix components can directly affect tissue years three scaffold designs have emerged for tissue en-
formation and wound healing. Bone morphogenetic pro- gineering purposes that fulfill these requirements. First-
teins (BMPs), for example, are some of the most potent ly, the materials must be conductive to desired cell types
local factors for induction or stimulation of bone forma- while blocking conduction of unwanted cell types. The
tion (22,28). Extracellular matrices are capable of en- second approach involves the inclusion of bioactive fac-
abling angiogenesis, recruitment of circulating progeni- tors into the synthetic scaffolds. The factors are chosen to
tor cells, and can undergo rapid scaffold degradation and encourage the infiltration of the appropriate cell types,
constructive remodeling of damaged or missing tissues and induce the formation of specific tissue phenotypes.
(2). The use of naturally occurring extracellular matrices The third approach is based on seeding scaffolds with cells
as cell-carrier materials has shown considerable promise in vitro, followed by implantation of the cell/scaffold
(3,24). construct (18). Studies of the interactions between extra-
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cellular matrix molecules and mapping sites of the inter- dure (Sigma Diagnostic Calcium Procedure, Sigma, St.
Louis, MO, USA). Briefly, the culture plate was washedaction to defined structural modules have led to the con-
cept that the function of an extracellular matrix depends with PBS without calcium and magnesium three times
each for 2 min. Cell and matrix were treated with 200largely on the polymers that it forms (1). By extension,
extracellular matrices formed in cell culture not only can µl 0.6 N HCl and 10 µl of sample was added into 300
µl calcium reaction buffer in a well of a 96-well plate.represent naturally occurring polymers, but can also incor-
porate and release endogenous growth factors (2). Fur- Five minutes later, the color reaction was measured us-
ing an ELISA plate reader at a wavelength of 575 nm.thermore, growth factors are much more effective when
used in conjunction with cofactors and regulatory proteins,
Reverse Transcriptase Polymerase Chainsuch as those found within various extracellular matri-
Reaction (RT-PCR) and Quantitative RT-PCRces. Therefore, the use of extracellular matrix materials
(Real-Time RT-PCR)as scaffolds may provide an optimal environment for the
Expression of mRNAs for alkaline phosphatase (ALP),repair and regeneration of tissues.
BMP-2 and -4, osteopontin (OPN), osteocalcin (OCN),The purpose of this investigation was to form a bone
and bone sialoprotein (BSP) was examined by RT-PCRmatrix scaffold in vitro by culturing osteoblasts under min-
and further quantified by real-time PCR. Total RNA waseralizing conditions and subsequently to deliver this com-
isolated using RNA isolation reagent (Advanced Bio-plex including osteoblasts into a critical size bone defect
technology, USA) and the concentration determinedwith the expectation of inducing new bone formation.
spectrophotometrically as described previously (9). First-MATERIALS AND METHODS
strand cDNA was synthesized from 1 µg RNA for 20 µl
The experimental protocol for using human cells in RT reaction using M-MLV reverse transcriptase (Pro-
this animal study was approved by the University Ani- mega, Madison, WI, USA) with Oligo dT as the primer.
mal Experimental Ethics Committee, University of Queens- The primers that were designed for PCR and real-
land. time PCR are listed in Tables 1 and 2. PCR was per-
formed with 2 µl cDNA, 1 U Red Hot Taq polymeraseIsolation and Culture of Osteoblasts
(Sigma), and 10 pmol of each primer in 20 µl reactionFrom Alveolar Bone
mixture for 31 cycles. Each cycle consisted of 95°C forHuman osteoblasts used for this study were isolated
1 min, 55°C for 30 s, and 72°C for 1 min. The PCRfrom alveolar bone as described previously (5,29). Brief-
products were then electrophoresed in 2% agarose gel.ly, normal human alveolar bone specimens were ob-
Real-time RT-PCR procedures were followed using thetained from healthy young patients and were first treated
company protocols (Applied Biosystems, Foster City, CA,by collagenase digestion and then used as explants for
USA). Briefly, primers were selected for each targetestablishment of cell culture. The cells obtained were
gene, using Primer Express software (Applied Biosys-subcultured and characterized by morphological and func-
tems). The PCR reaction mix contained cDNA, primerstional criteria. The cells were maintained in culture in (at individually optimized concentrations of 300–90075-cm2 flasks containing Dulbecco’s modified Eagle’s
nM), and SYBR Green Master mix (Applied Biosystems),medium supplemented with 10% (v/v) heat-inactivated
which provides nucleotides, PCR buffer, and AmpliTaqfetal calf serum (FCS), 1% penicillin/streptomycin, and
Gold DNA polymerase as well as the double-strand1% nonessential amino acids.
DNA fluorescent dye, SYBR green and the internal pas-Confluent cultures of osteoblasts between 4 to 8 pas-
sive reference dye, ROX. Samples were amplified in 96-sages were trypsinized and the released cells were sus-
well microplates in an ABI Prism 7700 System using apended in culture medium containing 10% FCS. Ali-
two-step cycling protocol. The cycle number at whichquots (1 ml) of cells at a density of 4.5 × 105/ml were
the SYBR green fluorescence crosses the threshold wasseeded in each well of six-well cell culture plates (Nunc,
calculated (CT). Results were normalized by being ex-Nalge Nunc International, Denmark) in 2 ml normal cul-
pressed relative to the amount of β-2 microglobulin mRNAture medium for 6 days. The cell culture medium was
determined in each sample.changed to mineralization culture medium, which con-
tained 50 µg/ml ascorbic acid, 10 mM β-glycerophos- Surgical Procedure
phate, and 10 µM dexamethasone, for a further 3 weeks.
Six- to 8-week-old SCID mice (C.B-17-lgh-Prkdc/Cells from three different donors were studied and each
SCID purchased from Animal Resource Centre, WA,cell line was studied in triplicate.
Australia) were anesthetized with an IP injection of a 1:
Calcium Measurement 1:8 solution of ketamine hydrochloride (Troy Labora-
tories, NSW, Australia), xylazine (Troy Laboratories), andCalcium deposition during the culture of osteoblasts was
assessed using a standard calcium measurement proce- 0.9% physiological saline at a dose of 0.1 ml per mouse
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Table 1. Primers for RT-PCR
Gene Forward Reverse Product Size
ALP ACGTGGCTAAGAATGTCATC CTGGTAGGCGATGTCCTTA 475 bp
β-2M CCCCCACTGAAAAAGATGAG TCACTCAATCCAAATGCGGC 102 bp
BMP-2 CAATAGCAGTTTCCATCACC ACAACCTTTTCATTCTCGTC 654 bp
BMP-4 GAAGAAGAATAAGAACTGCC CATCCCTCTACTACCATCTC 309 bp
BSP CAGAGGAAGCAATCACCA GAAGCTGGATTGCAGCTA 399 bp
OCN CATGAGAGCCCTCACA AGAGCGACACCCTAGAC 313 bp
OPN CCAAGTAAGTCCAACGAAAG GGTGATGTCCTCGTCTGTA 347 bp
weighing approximately 30 g. A linear incision, 1 cm until decalcification, as checked by radiographic exami-
nation, was complete. Tissues were then trimmed, dehy-long, was made in the left skull to reveal the bone sur-
face. The periosteum was dissected from the bone sur- drated in graded ethanol solutions, and then embedded
in paraffin. Serial sections of 5 µm were cut and moun-face and a full-thickness calvarial bone defect of 3.5 mm
in diameter was created using a trephine bur in a slow- ted on poly-lysine glass slides.
All sections were stained with hematoxylin and eosinspeed dental drill. To prevent overheating, 0.9% physio-
logical saline was dropped onto the contact point be- for general assessment of the tissue and wound healing.
Cell–matrix complexes were also stained using the vontween the bur and bone. Care was taken to avoid injury
to the dura in all animals. In vitro produced extracellular Kossa method for examination of calcification
matrix and cells cultured for 3 weeks in mineralizing
Immunohistochemistrymedia were washed three times with PBS and gently
The sources of antibodies used in this study are listedscraped from the culture well. The cell–matrix complex
in Table 3. Monoclonal anti-human bone ALP antibodywas filled and packed into the bone defect, and soft tis-
was from Sigma-Aldrich Inc. (St. Louis, MO, USA). Goatsues above the defect were closed using skin staples.
anti-human BMP-2 and -4 polyclonal antibody was pur-Control mice had the calvarial defect without filling
chased from Santa Cruz Biotechnology, Inc. (Santa Cruz,with the matrix complex.
CA, USA). Goat anti-human OCN polyclonal antibody
Histology was from Biomedical Technologies, Inc. (Stoughton,
MA, USA). Rabbit anti-human OPN (LF-7), BSP (LF-For histological examination, the 3-week cell cultures
in mineralizing medium were washed in PBS and fixed 6), collagen type I (LF-67) and collagen type III (LF-71
polyclonal antibodies were a generous gift from Dr. L.in 4% paraformaldehyde in PBS at pH 7.4 for 30 min
at room temperature. The cells, and their newly formed W. Fisher (Bone Research Branch, National Institute of
Dental Research, National Institute of Health, Bethesda,matrix, were then scraped off the culture well and em-
bedded in paraffin. Serial 5-µm sections were cut and MD, USA) (10).
Prior to immunoperoxidase staining, endogenous per-mounted on poly-lysine-coated glass slices.
For the animal experiments, animals were sacrificed oxidase activity was quenched by incubating the tissue
sections with 3% H2O2 for 20 min. All sections were8 weeks after surgery and the defect areas were dissected.
The tissue biopsies were fixed in 4% paraformaldehyde blocked by 0.1% bovine serum albumin (BSA) with 10%
swine serum. Sections were then incubated with optimalfor 12 h at room temperature. Tissues were decalcified
in 10% EDTA with changes twice a week for 2–3 weeks dilution of primary antibody for type I collagen (1:5000),
Table 2. Primers for Real-Time RT-PCR
Gene Forward Reverse Product Size
ALP CGTGGCTAAGAATGTCATCATGTT TGGTGGAGCTGACCCTTGA 89 bp
β-2M ACTTTGTCACAGCCCAAGATAGTTAA AAATGCGGCATCTTCAACCT 76 bp
BMP-2 AAAACGTCAAGCCAAACACAAA GTCCACGTACAAAGGGTGTCTCT 72 bp
BMP-4 GCCAAGCGTAGCCCTAAGC GTGGCGCCGGCAGTT 65 bp
BSP GGCCTGTGCTTTCTCAATGAA GCCTGTACTTAAAGACCCCATTTTC 96 bp
OCN GCAAAGGTGCAGCCTTTGTG GGCTCCCAGCCATTGATACAG 80 bp
OPN ACATCCAGTACCCTGATGCTACAG GGCCTTGTATGCACCATTCA 347 bp
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Table 3. Sources of Antibodies
Protein Antibody Source
Type I collagen anti-human type I collagen Dr. L. W. Fisher, NIH, Bethesda, MD, USA
Type III collagen anti-human type III collagen Dr. L. W. Fisher, NIH, Bethesda, MD, USA
Alkaline phosphatase (ALP) anti-human ALP Sigma-Aldrich, St. Louis, MO, USA
Bone morphogenetic protein-2 & -4 (BMP-2/-4) goat anti human BMP-2/-4 Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA
Osteocalcin (OCN) goat anti-human OCN Biomedical Technologies Inc., Stoughton, MA,
USA
Osteopontin (OPN) rabbit anti-human OPN Dr. L. W. Fisher, NIH, Bethesda, MD, USA
Bone sialoprotein (BSP) rabbit anti-human BSP Dr. L. W. Fisher, NIH, Bethesda, MD, USA
type III collagen (1:3000), ALP (1:200), BMP-2 and -4 addition of a biotinylated anti-fluorescein antibody (In-
noGenex), followed by placing enough streptavidin-(1:100), OCN (1:2000), OPN (1:2000), and BSP (1:100)
overnight at 4°C. Sections were then incubated with a horseradish peroxidase conjugate to cover the slice, and
finally DAB (diaminobenzidine) was added onto the sec-biotinylated swine-anti-mouse, rabbit, goat antibody
(DAKO Multilink, CA, USA) for 15 min, and then incu- tions for visualization. All sections were lightly counter-
stained with eosin.bated with horseradish perioxidase-conjugated avidin-
biotin complex (ABC) for 15 min. Antibody complexes
RESULTSwere visualized after the addition of a buffered diamino-
Cells derived from alveolar bone, cultured in DMEMbenzidine (DAB) substrate for 4 min. The reaction was
containing 10% FCS, and supplemented with ascorbicstopped by immersion and rinsing of sections in PBS.
acid, β-glycerophosphate, and dexamethasone, maintainedSections were then lightly counterstained with Mayer’s
a typical osteoblast phenotype with the formation ofhematoxylin and Scott’s blue for 40 s each, in between
nodular colonies after 2 weeks. As cell density in culture3-min rinses with running tap water. Following this,
increased, more extracellular matrix was laid down onthey were dehydrated with ascending concentrations of
the culture plate substrate. A thick layer of matrix and cellethanol solutions, cleared with xylene, and mounted with
complex formed in the following 2–3 weeks. Cell aggre-a coverslip using DePeX mounting medium (BDH Lab-
gation was detected in most of the cultures, and this celloratory Supplies, England).
and matrix complex showed a tendency to detach fromControls for the immunostaining procedures included
the culture substrate after 3 weeks. Calcium deposition,conditions where the primary antibody or the secondary
as monitored by a chromogenic agent, steadily increased(anti-mouse IgG) antibody was omitted. In addition an
and reached a peak level at 12 days (Fig. 1).irrelevant antibody (anti-CD-15), which was not present
in the test sections, was used as a control.
Cell–Matrix Complex
In Situ Hybridization Histological assessment of the cell and matrix com-
plex revealed a tissue structure with a “connective tis-To verify the origin of cells that formed bone tissue
in this study, in situ hybridization (ISH) was performed sue”-like morphology, which contained cells entrapped
within an extracellular matrix. The cells embedded inusing a human-specific fluorescein-labeled oligonucleo-
tide probe (InnoGenex, San Ramon, CA), which detects the matrix were not oriented in any particular manner
and, although the extracellular matrix was abundant, noAlu repeat sequences found in human chromosomes. ISH
was carried out by using a universal ISH kit (Inno- obvious fiber bundles were observed (Fig. 2A). Calcifi-
cation of this complex was not uniform, with most cal-Genex, San Ramon, CA). Briefly, tissues were dewaxed
with RNase-free reagents, then treated with proteinase cium deposition being located on the periphery (Fig.
2B). Immunohistochemistry showed that the major com-K for 10 min and heated to boil under microwave. The
slices were postfixed in 1% formaldehyde solution for ponents in extracellular matrix (ECM) were type I colla-
gen, which distributed throughout the ECM as ribbon-10 min. One drop of the ready-to-use probe solution was
added onto the sections and the slices were covered with like structure (Fig. 2C). Type III collagen stained only
faintly in some ECM areas, but it was most associateda plastic coverslip. After heating in a moist chamber at
85°C for 5 min, the slices were incubated at 37°C over- with cells (Fig. 2D).
The distribution of the bone-related proteins ALPnight for the hybridization reaction. After posthybridiza-
tion washes, the bound probe was detected by serial (Fig. 3A), BMP-2 and -4 (Fig. 3B), OCN (Fig. 3C), BSP
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Figure 1. Calcium levels measured by a chromogenic agent in cultured alveolar bone cells, under
mineralizing and nonmineralizing conditions. Calcium levels deposited on culture substrate started
to increase significantly after 3 days (p < 0.05, ANOVA) and reached the peak level at 12 days
and kept in this high level thereafter. *p < 0.05 relative to control culture media.
Figure 2. Histology of the cell–matrix complex formed under differentiation culture. (A) Connective tissue expression by H&E
staining. (B) Matrix mineralization by von Kossa staining. (C) Type I collagen expression and (D) type III collagen expression, by
immunohistochemistry. Bar = 400 µm.
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Figure 3. Expression of bone matrix proteins in the cell–matrix complex determined by immunohistochemical staining. (A) ALP,
(B) BMP-2 and -4, (C) OCN, (D) BSP, (E) OPN, (F) von Kossa staining. Arrows indicate colocalization of BSP, OPN, and calcium
in the areas of mineralization. Bar = 50 µm.
(Fig. 3D), and OPN (Fig. 3E) in the cell–matrix com- of ALP, BMP-2 and -4, and OCN. In general, staining
for OCN showed more positive cells with a stronger cel-plex was determined by immunohistochemical staining.
ALP, BMP-2 and -4, and OCN were most strongly lo- lular staining than cells expressing ALP and BMP-2
and -4. It was also found that not all of the cells stainedcalized in the cells and their immediate matrix, whereas
staining of the body of the ECM was moderate. There consistently for these molecules. In contrast, BSP and
OPN were demonstrated in the areas of ECM with onlywere subtle differences between the cellular expression
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moderate expression in some cells. Interestingly, BSP Surgical Bone Defects
and OPN colocalized with areas of calcification (von Representative examples of the light microscopy and
Kossa staining) (Fig. 3F). tissue histology of the bone defects 8 weeks after surgery
are illustrated in Figure 6. An obvious increase in light
Gene Expression and Bone-Related Proteins opacity was noted in bone defects filled with the ECM
containing osteoblasts. Light microscopy revealed thatAfter 3 weeks of culture in mineralizing media, gene
expression for bone-related proteins was monitored by the size of bone defects filled with mineralized matrix
containing osteoblasts (Fig. 6B) was smaller comparedRT-PCR and further quantified by real-time PCR (Figs.
4 and 5). Interestingly, compared with the normal cul- with the control (Fig. 6A). There was no histological
evidence of an inflammatory reaction in any of the treat-ture of osteoblasts, mineralizing conditions resulted in sig-
nificant expression of mRNA for all of the bone-related ment groups at this stage. In the control group, unfilled
calvarial defects were covered with thin fibrous connec-molecules (ALP, BMP-2, BMP-4, BSP, OPN, and OCN)
selected for the study (p < 0.05). tive tissue sheets without new bone formation (Fig. 6C).
Figure 4. Comparison of mRNA expression of bone-related proteins in osteoblasts cultured in
mineralizing medium and normal culture medium by RT-PCR. Stronger bands were detected in
osteoblasts cultured in mineralizing culture conditions (band 2) compared with normal culture
conditions (band 1) in ALP, BMP-2, BMP-4, BSP, OCN, and OPN whereas there is no difference
in the expression of β-2M mRNA.
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Figure 5. mRNA expression of bone-related proteins from alveolar bone cells in mineralizing and
normal media were quantified by real-time PCR. In mineralizing medium, human alveolar bone
cells showed a significant upregulation of ALP, BMP-2, BMP-4, OCN, BSP, and OPN mRNA.
*p < 0.05 relative to normal culture medium.
Bone defects, filled with mineralized matrix containing enchymal cells to osteoprogenitor cells during the repair
of the bone defects.osteoblasts, showed new bone formation and increased
amounts of fibrous tissue and cells within the defects
DISCUSSION(Fig. 6D, G). In addition, mineralized bony trabeculae
Recently, a focus of tissue engineering has been thelined by osteoblasts were found.
synthesis of artificial constructs or tissues based on the
Bone Cell Specificity implantation of vital cells or cell matrix into sites of tis-
sue damage. Many synthetic and natural extracellularTo determine the origin of the bone-forming cells
within the defects, and to localize implanted human os- matrices have been used as scaffold materials for tissue
engineering approaches (13,14,17,18). Natural extracel-teoblasts, in situ hybridization was carried out to trace
the human-specific Alu sequence (Fig. 6F, H). No hy- lular matrices used as scaffolds show a good biocompat-
ibility for cell culture in vitro and subsequent tissue for-bridization signal was found in the sections from control
groups of bone defects. Nor was any signal detected in mation in vivo (2,3,23). For example, the dermis is one
such source that allows the extraction of cells and pro-the mouse tissues surrounding the implants. In the group
containing human osteoblasts, strong staining for Alu se- duction of a slightly modified form of human dermal
extracellular matrix. However, there are limited loca-quence was found in the nuclei of the cells associated
with the newly formed bone tissue and was particularly tions within the body that can be used as an easily acces-
sible source of naturally occurring extracellular matriceslocated in cells lining the newly formed bone. However,
other osteoblasts, and nearly all of the osteocytes within in significant quantities (3). The present study demon-
strates the use of extracellular matrix formed by cellsnewly formed bone, failed to stain for the Alu sequence.
These results indicate that implants with human differ- derived from alveolar bone as a scaffold material to de-
liver differentiated osteoblasts into a bone defect of criti-entiated osteoblasts and developed matrix were not only
involved in direct bone formation but also exerted an cal size to induce new bone formation. Extracellular ma-
trix formed by osteoblasts in vitro represents a prototypeosteoinductive role inducing differentiation of host mes-
FACING PAGE
Figure 6. Histological evaluation of tissue reaction after 8 weeks of implantation of cell–matrix complex into bone defects.
(A) Light microscopy of control bone defect. White arrows indicate the boundary of the bone defect. (B) Light microscopy of bone
defect filled with cell–matrix complex. White arrows indicate the boundary of the bone defect. (C) H&E-stained control bone
defect shows no new bone formation. (D) Bone defect filled with cell–matrix complex shows new bone formation. Arrows indicate
the rim of defects. NB, new bone. Bar = 400 µm for (C, D). (E, F) In situ hybridization of human-specific Alu sequence in a tissue
section with human alveolar bone cells implanted. (E) H&E staining, (F) in situ hybridization. Arrows indicate the rim of the
defect. NB, new bone. Arrowheads indicate positive labeling of Alu sequence. Bar = 100 µm for (E, F). (G) Higher magnification
of the selected part of (D). Bar = 1400 µm. (H) Higher magnification of selected part from (F). Bar = 350 µm.
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of naturally occurring bone matrix. In culture, the osteo- els of bone-related proteins. This graft not only provided
a structural framework but also provided a means to de-blasts were normally confluent and formed a multilay-
ering cell sheet. In our experiments, we found that in liver differentiated osteoblasts to the bone defect.
New bone formation appeared to arise from both themineralizing media alveolar bone-derived cells could form
a cell and matrix complex, and this complex had a ten- transplanted cells (as judged by their staining for the
human-specific Alu gene) and the host mesenchymaldency to detach from the culture substrate after 3 weeks.
This phenomenon made it easy to collect this cell and cells (as judged by their negative staining for the Alu
gene). The controls consistently demonstrated no newmatrix complex to be used as a scaffold for cell transplan-
tation studies. It has been found that osteoblasts and bone bone formation. Accordingly, because no new bone formed
in the control groups, it seems that the host cells weremarrow stromal cells under mineralizing conditions can
form a collagenous bone matrix and, due to dystrophic unable to initiate new bone fill of the defect without the
aid of implanted osteoblasts. These findings are consis-mineral deposition, this layer of matrix has a tendency to
separate from the culture substrate (20). Similarly, a layer tent with other studies in which it has been determined
that implants with differentiated osteoblasts and devel-of mineralized matrix formed by culture of osteoblasts on
dental implant surfaces has been found to increase the oped matrix are not only involved in direct bone for-
mation, but also appear to be osteoinductive, inducingpotential osseointegration ability and contribute to im-
proved engineering of endosseous implants (8). differentiation of host mesenchymal cells into osteopro-
genitor cells during the repair of the critical-size boneTissue engineering of human bone is a complex pro-
cess, as the functional development of bone cells re- defects (19,26,27).
In conclusion our study demonstrates that a cell andquires that regulatory signals be temporally and spatially
ordered. The characteristics of the intact bone extracel- matrix complex with osteogenic potential can be formed
in vitro by human alveolar bone cells. The complexeslular matrix that distinguishes it from other scaffold
materials is the diversity of structural proteins and asso- could be successfully implanted into osseous defects and
resulted in new bone formation. However, more detailedciated bioactive molecules and their unique spatial dis-
tribution (2). The matrix formed by alveolar bone cells analyses are now needed to determine the nature of the
infiltrating host mesenchymal cells to determine whethercontained several structural and functional proteins of
bone tissue. Type I collagen, which is the predominant they are of stem cell origin or of an already committed
phenotype.collagen found in bone, was the major matrix compo-
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